Categories: News

New Multicenter Study Demonstrates SyMRI’s Potential to Transform Clinical Neuroimaging Workflows

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

LINKÖPING, Sweden, June 3, 2025 /PRNewswire/ — SyntheticMR AB (publ) is proud to share the results of a newly published multicenter clinical study in the American Journal of Neuroradiology (AJNR), demonstrating the diagnostic equivalence—and potential advantages—of SyMRI® using the 3D-QALAS method compared to conventional 3D MRI in routine clinical neuroimaging. 

The peer-reviewed study, available here, evaluated a large and diverse patient population across multiple imaging centers. The findings confirmed that 3D synthetic MRI using SyMRI matched conventional MRI in sensitivity, specificity, and diagnostic accuracy. Notably, SyMRI received even higher ratings for image quality. 

“These results underscore the value of SyMRI in real-world clinical practice,” said Johanna Norén, Acting CEO of SyntheticMR. “With diagnostic performance on par with conventional imaging—and with added benefits in workflow efficiency and quantitative imaging—SyMRI has the potential to enhance diagnostic confidence while streamlining MRI protocols.” 

The study highlights SyMRI’s ability—particularly in 3D—to deliver quantitative, multi-contrast images in a single, fast scan without compromising image quality, making it a strong candidate for advancing scalable and standardized neuroimaging practices. 

This clinical evidence further strengthens SyntheticMR’s mission to redefine MRI efficiency, bringing the power of objective, quantitative imaging into routine clinical use. 

For additional information, please contact Johanna Noren, acting CEO, SyntheticMR AB, johanna.noren@syntheticmr.com; +46 70 619 21 00 

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/syntheticmr-ab/r/new-multicenter-study-demonstrates-symri-s-potential-to-transform-clinical-neuroimaging-workflows,c4158230

The following files are available for download:

 

View original content:https://www.prnewswire.com/news-releases/new-multicenter-study-demonstrates-symris-potential-to-transform-clinical-neuroimaging-workflows-302471723.html

SOURCE SyntheticMR AB

Staff

Recent Posts

Red Light Holland Receives Initial Third-Party Psilocybin Testing Results via FDA-Compliant, DEA-Registered Partner, Irvine Labs

Initial testing results confirm psilocybin potency and process validation for potential medical grade manufacturing applicationsIrvine…

15 minutes ago

Elucent Medical Launches SmartSupport™ – A Smarter Standard in Surgical Support 

MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce the launch…

15 minutes ago

Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine

First-in-human trial of Capricor’s StealthX™ vaccine initiated under HHS’s Project NextGenTrial conducted and funded by…

15 minutes ago

Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development

PRESS RELEASE - 08/18/2025, 09:00 AM EDT Biocartis Welcomes Mike Kreitzinger as Senior Vice President…

16 minutes ago